Target Name: LOC107987282
NCBI ID: G107987282
Other Name(s): uncharacterized LOC107987282 | Uncharacterized LOC107987282

LOC107987282: A Potential Drug Target and Biomarker

LOC107987282 is a novel gene that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located on chromosome 6p21.2 and has been shown to play a role in the development and progression of various diseases, including cancer.

The discovery of LOC107987282 as a potential drug target and biomarker has significant implications for the development of new treatments for these diseases. By targeting this gene, researchers can gain insights into the underlying mechanisms of the disease and develop targeted therapies that can effectively treat it.

In addition to its potential as a drug target, LOC107987282 has also been identified as a potential biomarker for various diseases. The expression of this gene has been shown to be associated with the development of cancer, as well as other diseases, such as cardiovascular disease and neurological disorders.

The implications of these findings are significant, as they suggest that LOC107987282 may be a useful biomarker for the diagnosis and treatment of various diseases. Researchers can use this information to develop new diagnostic tests and to identify potential targets for therapy.

LOC107987282 has also been shown to play a role in the regulation of cellular processes that are essential for the growth and development of tissues. The expression of this gene has been shown to be involved in the regulation of cell proliferation, apoptosis (programmed cell death), and cell adhesion.

These findings have important implications for the development of new therapies for various diseases, including cancer. By targeting the regulation of cell proliferation and apoptosis, researchers can develop new treatments that can effectively stop the growth and spread of cancer cells.

In conclusion, LOC107987282 is a novel gene that has significant potential as a drug target and biomarker. Its expression has been shown to be involved in the development and progression of various diseases, including cancer. These findings have important implications for the development of new treatments for these diseases. Further research is needed to fully understand the role of LOC107987282 as a drug target and biomarker.

Protein Name: Uncharacterized LOC107987282

More Common Targets

LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386 | LOC143666 | LOC145474 | LOC145845 | LOC148430 | LOC148696 | LOC149351 | LOC149684 | LOC151760 | LOC153893 | LOC153910 | LOC154449 | LOC154761 | LOC155060 | LOC157273 | LOC158434 | LOC158435 | LOC158696 | LOC162137 | LOC202181 | LOC221946 | LOC254896 | LOC260339 | LOC283028 | LOC283038 | LOC283045 | LOC283070 | LOC283194 | LOC283278 | LOC283299 | LOC283683 | LOC283731 | LOC283788 | LOC284009 | LOC284191 | LOC284240 | LOC284344 | LOC284379 | LOC284412 | LOC284581 | LOC284600 | LOC284788 | LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090